Pops is focused on improving the current healthcare model. With diabetes as one of our most expensive chronic conditions in the world, we have not significantly changed how we manage diabetes in the last twenty-five years. Even the newest digital health companies continue to treat people with diabetes as patients to manage remotely with their live coaches. This model is lacking.
Pops has no live coaches and no traditional test kits. We don't see people as patients we need to manage. We see people who just want to live their life. Pops believes that if you give people a great enough consumer experience through a tech platform, they will choose to take care of their condition. This is a fundamental transformation in healthcare. A similar type of shift has already happened in other industries (e.g. for travel, people now book trips through their phone rather than via a travel agent).
Pops has developed an AI Virtual Health Assistant named Mina, who supports the user 24/7 in a non-judgmental way. We pair with Mina the Rebel meter, our simple method to measure blood sugar. This platform has FDA approval and is being sold in the U.S. Pops generated industry-unique clinical data that has been accepted for publication at the American Diabetes Association 2021 session demonstrating a significant glucose drop for 18 months of sustained use!
Pops is sold as a B2B2C subscription model. We used 2020 as a time to generate contracts with strategic partners and innovative health plans. We recently were one of the winners of the Zurich Innovation Challenge and are starting a paid sales pilot in Australia with Zurich. Zurich is an example of our focus on non-traditional health channels who are offering digital wellness.
With multiple contracts in place, Pops has demonstrated over a 90% month-over-month user growth on the platform in Q1 2021.